Evidence map›Paper›PMID 31806938›Full record

ArticlePatient preference and adherence2019

Pilot Testing Of A Brief Pre-Consultation Screener For Improving The Identification And Discussion Of Medication Adherence In Routine Consultations.

John Weinman, Imran Ali, Anna Hodgkinson, Martha Canfield, Christina Jackson

Abstract read
In one paragraph

Article in Patient preference and adherence, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

John WeinmanMedicines Use Group, Institute of Pharmaceutical Sciences, Kings College London, London SE1 9NH, UK.
Imran AliMedicines Use Group, Institute of Pharmaceutical Sciences, Kings College London, London SE1 9NH, UK.ORCID 0000-0002-3802-9998
Anna HodgkinsonNHS Lambeth Diabetes Team, Crown Dale Medical Centre, London SE19 3NY, UK.ORCID 0000-0001-9375-4511
Martha CanfieldHealth Psychology Section, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London SE1 9RT, UK.
Christina JacksonMedicines Use Group, Institute of Pharmaceutical Sciences, Kings College London, London SE1 9NH, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOne of the challenges in being able to identify and manage medication adherence problems in routine practice is that patients are often reluctant to "admit to" non-adherence, particularly when asked in a direct way. The study reported in this paper has been designed as part of an attempt to address this problem by examining the value of a new brief medicines use screener in helping patients to identify and discuss adherence issues in a clinical setting.

methods145 Patients with type 2 diabetes completed the new screener (MMWFU) together with an adherence self-report scale (MMAS4) and medication beliefs questionnaire (BMQ). Correlations between the scales were assessed together with an assessment of the sensitivity and specificity of the new screener.

results126 (88%) of the sample identified at least one medicines-related issue on the MMWFU, which showed strong correlations with the MMAS4 and BMQ Concerns scales, as well as good sensitivity and specificity against the MMAS4.

conclusionThe results indicate that the new screener can serve as a fairly sensitive indicator of non-adherence and its determinants. Future studies will be needed to establish how well it performs in other clinical settings.

Indexed as

adherence assessmentbrief screenermedication adherencemedication beliefs

Identifiers

PMID31806938
PMCPMC6842708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.